[Pharmacological treatment of multiple sclerosis].
Relapses in multiple sclerosis, associated with significant functional impairment, should be treated with methylprednisolone. In case of repeated relapses or onset cases of multiple sclerosis there is an indication for preventive treatment with interferon-beta/glatiramer acetate (first-line treatment), natalizumab (second-line treatment) or mitoxantrone (third-line treatment).
Myhr
Kjell-Morten
KM
Nasjonalt kompetansesenter for multippel, sklerose, Nevrologisk avdeling, Haukeland universitetsykehus, 5021 Bergen. kjell-morten.myhr@helse-bergen.no
D000700:Analgesics / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D004359:Drug Therapy, Combination; D000068717:Glatiramer Acetate; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D008942:Mitoxantrone / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D010455:Peptides / Q000627:therapeutic use; D055502:Secondary Prevention
D000700:Analgesics; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000069442:Natalizumab; D010455:Peptides; D000068717:Glatiramer Acetate; D016899:Interferon-beta; D008942:Mitoxantrone; D008775:Methylprednisolone
Medikamentell behandling av multippel sklerose.